Michael Mercandetti, MD
Ophthalmic Plastic and Reconstructive Surgery · Venice, FLNPI 1669471959
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,072 and has fallen 95.7% since, to $46 in 2025. That places this record below the midpoint for ophthalmic plastic and reconstructive surgery clinicians in FL, where the typical reported total is $1,956.
Across 48 payments — averaging $39.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$353
- Kerecis Limited$297
- AbbVie$292
- Amgen$251
- ANI Pharmaceuticals, Inc.$165
- Johnson & Johnson Surgical Vision, Inc.$147
- plus $385 from 10 others
What the payments were for
- Speaking & faculty fees$1257%
- Food & beverage$1,76693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 15 | $353 |
| Kerecis Limited | 2 | $297 |
| AbbVie | 7 | $292 |
| Amgen | 5 | $251 |
| ANI Pharmaceuticals, Inc. | 6 | $165 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $147 |
| Bausch & Lomb Americas Inc. | 1 | $122 |
| Merz North America, Inc. | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Convatec Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $26 |
| Biotissue Holdings Inc. | 1 | $23 |
| Alcon | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Ocular Therapeutix, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$609
- Kerecis Omega3 Marigen$578
- Kerecis Omega3 GraftGuide$297
- Tecnis IOL$147
- VUITY$125
- TEPEZZA$125
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
- MIEBO$122
How this compares
$1,891 in reported general payments places this provider in the 45th percentile of 37 ophthalmic plastic and reconstructive surgery providers in Florida.
See all ophthalmic plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 68 | $627 |
| ErythromycinErythromycin Base | 63 | $563 |
| Mupirocin | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Venice
- John FezzaVenice$3.6M
- Wendy LeeMiami$616K
- Jennifer MurdockMiami$316K
- Ana VictoriaMiami$130K
- Keshini ParbhuWindermere$102K
- Sara WesterMiami$78K
- Robert ApplebaumLakeland$39K
- Yasaman MohadjerSt Petersburg$6K
- William MackTampa$5K
- Gil EpsteinPlantation$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.